undefined undefined undefined

Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up

Event: ESC Congress 2021 - The Digital Experience

Topic: Mitral Valve Prolapse

Session: A deep dive into mitral regurgitation

Access

Like

Angiotensin II receptor blockers in modulation of transforming growth factor-beta effects on mitral valve myxomatous degeneration

Event: ESC Congress 2021 - The Digital Experience

Topic: Pathophysiology and Mechanisms

Session: Valvular heart disease and infective endocarditis e-posters

Access

Like

Midventricular obstruction and left ventricular remodeling after transcatheter aortic valve implantation

Event: EACVI - Best of Imaging 2020

Topic: Valvular Heart Disease

Session: ePoster session

Access

Like

Risk factors of persistent ventricular arrhythmias after mitral valve repair in Barlow disease patients: six-year follow-up

Event: EACVI - Best of Imaging 2020

Topic: Valvular Heart Disease

Session: ePoster session

Access

Like

Thoracic aorta and circulating transforming growth factor-b in marfan syndrome and marfanoid habitus

Event: EuroEcho 2019

Topic: Imaging of Aortic Disease

Session: Imaging: Aortic Disease

Access

Like

Effects of mitral valve repair on left ventricular remodeling and ventricular arrhythmia in mitral valve prolapse patients: five-year follow-up

Event: EuroEcho 2019

Topic: Valvular Heart Disease

Session: What is new in mitral valve intervention

Access

Like

Transforming growth factor-beta and arrhythmias in mitral valve prolapse patients

Event: ESC Congress 2019

Topic: Valvular Heart Disease

Session: Heart values

Access

Like

Effect of renin-angiotensin system blockade in prevention of thoracic aortic aneurysm progression

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Aortic disease: clinical and treatment

Access

Like

undefined undefined undefined

Contributor content

Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up

Angiotensin II receptor blockers in modulation of transforming growth factor-beta effects on mitral valve myxomatous degeneration

Midventricular obstruction and left ventricular remodeling after transcatheter aortic valve implantation

Risk factors of persistent ventricular arrhythmias after mitral valve repair in Barlow disease patients: six-year follow-up

Thoracic aorta and circulating transforming growth factor-b in marfan syndrome and marfanoid habitus

Effects of mitral valve repair on left ventricular remodeling and ventricular arrhythmia in mitral valve prolapse patients: five-year follow-up

Transforming growth factor-beta and arrhythmias in mitral valve prolapse patients

Effect of renin-angiotensin system blockade in prevention of thoracic aortic aneurysm progression

ESC 365 is supported by